Neupro (rotigotine)
4 mg/24h · Patch Extended Release
By UCB, Inc.
- NDC
- 50474-804
- Route
- Transdermal
- Therapeutic class
- Dopamine Agonists [MoA], Nonergot Dopamine Agonist
- Marketing category
- NDA
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

